These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 1400885)

  • 1. Epithelial hyperplasia and decreased colloid content of the thyroid gland in triiodothyronine-predominant Graves' disease.
    Takamatsu J; Takeda K; Katayama S; Sakane S; Morita S; Kuma K; Ohsawa N
    J Clin Endocrinol Metab; 1992 Oct; 75(4):1145-50. PubMed ID: 1400885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced thyroid iodine metabolism in patients with triiodothyronine-predominant Graves' disease.
    Takamatsu J; Hosoya T; Naito N; Yoshimura H; Kohno Y; Tarutani O; Kuma K; Sakane S; Takeda K; Mozai T
    J Clin Endocrinol Metab; 1988 Jan; 66(1):147-52. PubMed ID: 3335601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroidal triiodothyronine and thyroxine in Graves' disease: correlation with presurgical treatment, thyroid status, and iodine content.
    Larsen PR
    J Clin Endocrinol Metab; 1975 Dec; 41(06):1098-104. PubMed ID: 54364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathological characteristics of the thyroid gland in patients with triiodothyronine-predominant Graves' disease].
    Miki K; Takamatsu J; Sakane S; Majima M; Kitaoka H; Kitazawa A; Mozai T; Katayama S; Morita S; Kobayashi A
    Nihon Naibunpi Gakkai Zasshi; 1987 Mar; 63(3):184-92. PubMed ID: 3609395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistently increased gastrin and decreased pepsinogen concentrations in serum from some patients with Graves' disease of triiodothyronine-predominant type and common type.
    Fukao A; Takamatsu J; Shimamoto C; Kuma K; Ohsawa N
    Thyroid; 1998 Mar; 8(3):259-63. PubMed ID: 9545113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genes that characterize T3-predominant Graves' thyroid tissues.
    Matsumoto C; Ito M; Yamada H; Yamakawa N; Yoshida H; Date A; Watanabe M; Hidaka Y; Iwatani Y; Miyauchi A; Takano T
    Eur J Endocrinol; 2013 Feb; 168(2):137-44. PubMed ID: 23109646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
    Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
    J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ratio of serum triiodothyronine to thyroxine and the prognosis of triiodothyronine-predominant Graves' disease.
    Takamatsu J; Sugawara M; Kuma K; Kobayashi A; Matsuzuka F; Mozai T; Hershman JM
    Ann Intern Med; 1984 Mar; 100(3):372-5. PubMed ID: 6546484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reappraisal of the 3,5,3'-triiodothyronine-suppression test in the prediction of long term outcome of antithyroid drug therapy in patients with hyperthyroid Graves' disease.
    Yamada T; Koizumi Y; Sato A; Hashizume K; Aizawa T; Takasu N; Nagata H
    J Clin Endocrinol Metab; 1984 Apr; 58(4):676-80. PubMed ID: 6421866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.
    Sato A; Yamada T; Aizawa T; Ichikawa K; Komiya I; Takasu N; Takemura Y
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2173-7. PubMed ID: 7608274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of thioredoxin in patients with Graves' disease.
    Kihara M; Kontani K; Yamauchi A; Miyauchi A; Nakamura H; Yodoi J; Yokomise H
    Int J Mol Med; 2005 May; 15(5):795-9. PubMed ID: 15806300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased production of B-cell growth factor by T lymphocytes in Graves' thyroid: possible role of CD4+ CD29+ cells.
    Goto Y; Itoh M; Ohta Y; Ogawa N; Goto Y; Ohashi H
    Thyroid; 1997 Aug; 7(4):567-73. PubMed ID: 9292944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triiodothyronine generation from thyroxine in human thyroid: enhanced conversion in Graves' thyroid tissue.
    Ishii H; Inada M; Tanaka K; Mashio Y; Naito K; Nishikawa M; Imura H
    J Clin Endocrinol Metab; 1981 Jun; 52(6):1211-7. PubMed ID: 6894450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis.
    Amino N; Yabu Y; Miki T; Morimoto S; Kumahara Y; Mori H; Iwatani Y; Nishi K; Nakatani K; Miyai K
    J Clin Endocrinol Metab; 1981 Jul; 53(1):113-6. PubMed ID: 6165731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum thyrotropin in Graves' disease: a more reliable index of circulating thyroid-stimulating immunoglobulin level than thyroid function?
    Kabadi UM; Premachandra BN
    Endocr Pract; 2007 Oct; 13(6):615-9. PubMed ID: 17954417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease.
    Chen JJ; Ladenson PW
    J Clin Endocrinol Metab; 1986 Jul; 63(1):102-6. PubMed ID: 2423547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
    Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K
    J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute effects of corticosteroids on thyroid activity in Graves' disease.
    Williams DE; Chopra IJ; Orgiazzi J; Solomon DH
    J Clin Endocrinol Metab; 1975 Aug; 41(2):354-61. PubMed ID: 1174132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroxine and 3,5,3'-triiodothyronine content of thyroglobulin in thyroid needle aspirates in hyperthyroidism and hypothyroidism.
    Laurberg P
    J Clin Endocrinol Metab; 1987 May; 64(5):969-74. PubMed ID: 3558731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid peroxidase activity-inhibiting immunoglobulins in patients with autoimmune thyroid disease.
    Okamoto Y; Hamada N; Saito H; Ohno M; Noh J; Ito K; Morii H
    J Clin Endocrinol Metab; 1989 Apr; 68(4):730-4. PubMed ID: 2921308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.